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The genetic basis of cognition and behavioral adap-
tation to the environment remains poorly under-
stood. Here we demonstrate that the histone methyl-
transferase complex GLP/G9a controls cognition
and adaptive responses in a region-specific fashion
in the adult brain. Using conditional mutagenesis
in mice, we show that postnatal, neuron-specific
deficiency of GLP/G9a leads to derepression of
numerous nonneuronal and neuron progenitor genes
in adult neurons. This transcriptional alteration is
associated with complex behavioral abnormalities,
including defects in learning, motivation, and envi-
ronmental adaptation. The behavioral changes trig-
gered by GLP/G9a deficiency are similar to key
symptoms of the human 9q34 mental retardation
syndrome that is associated with structural alter-
ations of the GLP/EHMT1 gene. The likely causal
role of GLP/G9a in mental retardation in mice and
humans suggests a key role for the GLP/G9a-con-
trolled histone H3K9 dimethylation in regulation of
brain function through maintenance of the transcrip-
tional homeostasis in adult neurons.
INTRODUCTION
A possible clue to the genetic mechanisms underlying cognition
and environmental adaptation could be obtained through identi-
fication of genes responsible for mental retardation disorders.
Recent studies show that many of the proteins associated with
mental retardation syndromes in mice and humans are involved
in epigenetic control of gene expression (Chelly et al., 2006; Inlow
and Restifo, 2004; Kramer and van Bokhoven, 2009). It has been
found that altered expression of histone acetyltransferases and
deacetylases as well as of proteins involved in histone or DNA
methylation are associated with mental retardation syndromes
(Kramer and van Bokhoven, 2009). These epigenetic regulators678 Neuron 64, 678–691, December 10, 2009 ª2009 Elsevier Inc.govern expression of large numbers of potentially unrelated
genes.Yet, despite differences in specific functionsof thedistinct
epigenetic regulators and their targets, impairment of chromatin
function leads to symptomatically similar mental retardation
syndromes (Chelly et al., 2006; Inlow and Restifo, 2004; Kramer
and van Bokhoven, 2009). Therefore, it is conceivable that
mental retardation is triggered not by changes in specific target
gene(s) but by the inability of neurons to respond adequately
to environmental signals under conditions of greatly distorted
transcriptional homeostasis (Ramocki and Zoghbi, 2008).
Transcriptional homeostasis relies largely on the balance
between positive and negative regulation of gene transcription.
In mammals, di- or trimethylation of histone H3 on lysine 9
(H3K9me2 and H3K9me3) is commonly associated with gene
silencing in eu- or heterochromatin, respectively (Jenuwein and
Allis, 2001; Kouzarides, 2007; Zhang and Reinberg, 2001). The
H3K9me2 is catalyzed by an enzymatic complex comprised of
the histone methyltransferases G9a and G9a-like protein GLP
(Ogawa et al., 2002; Peters et al., 2003; Rice et al., 2003; Shi
et al., 2003; Tachibana et al., 2001; Tachibana et al., 2002,
2005). Genetic ablation of either of these proteins results in loss
of euchromatic H3K9me2 (Peters et al., 2003; Rice et al., 2003;
Sampath et al., 2007; Tachibana et al., 2001, 2002, 2005).Despite
the genome-wide distribution of H3K9me2, the scope and
pattern of gene expression changes in the absence of this mark
is rather limited and depends on the affected cell type (Kondo
et al., 2008; Sampath et al., 2007; Tachibana et al., 2002; Wags-
chal et al., 2008). It has been demonstrated recently that aberrant
function of G9a in nonneuronal cells leads to derepression of
neuronal genes outside of the nervous system (Ding et al.,
2008;Roopra et al., 2004; Tahiliani et al., 2007). This finding raises
a question about the potential ability of the GLP/G9a complex to
function as a master regulator of lineage-specific gene expres-
sion in the brain. In support of this model, we show that postnatal
neuron-specific ablation of the histone methyltransferases GLP/
G9a leads to derepression of nonneuronal and early neuron
progenitor genes in various brain areas. We also demonstrate
that these changes in gene expression are associatedwith cogni-
tive and behavioral defects in adult mice. The impaired brain
function manifests itself either by a mental retardation-like
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Figure 1. Conditional Ablation of GLP/G9a in Postnatal Neurons in the Forebrain
(A) Strategy forGLP gene targeting. The partial map of theGLP locus and the map of GLP targeting vectors are shown. Exon 23 ofGLP, which encodes for amino
acids 1028–1037 within the catalytic SET domain, was flanked with loxP sites in ES cells followed by a routine procedure for generation of GLPfl/fl mice. Exons,
unfilled rectangles; loxP sequences, filled triangles; FRT sequences (shaded octagons) that flank neoR gene were removed from the targetedGLP locus in vivo by
using FLP recombinase-transgenic mice. DTA, diphtheria toxin gene; TK, thymidine kinase gene; LAH/SAH, long/short arm of homology. Following BsrGI (B)
digestion, DNA probe B was used to identify the targeted GLP locus.
(B) Conditional neuron-specific ablation of GLP in the mouse forebrain. Postnatal, neuron-specific ablation of GLP in the mouse forebrain was achieved by
breeding GLPfl/fl mice to Camk2a-Cre mice. Deficiency of GLP in neurons of the (1) cortex, (2) hippocampus, and (3) striatum was confirmed by comparative
immunohistochemical analysis of GLP protein expression in the forebrain of 6-week-old Camk2a-Cre; GLPfl/fl mice. Dotted lines indicate neuronal layer; arrow-
heads indicate examples of nonneuronal cells.
(C) Reduced euchromatic H3K9me2 levels in GLP- or G9a-deficient neurons. Nuclear H3K9me2 distribution (red) in GLP (left panel) andG9a (right panel) deficient
and control hippocampal neurons was analyzed by anti-H3K9me2 immunofluorescence; DNA was visualized by Draq5 staining (blue), diffuse blue staining indi-
cates euchromatic DNA, punctate blue staining indicates heterochromatic DNA.syndrome in mice with forebrain-specific ablation of GLP/G9a
or by more selective behavioral defects that follow GLP/G9a
deficiency in specialized neuronal subpopulations. Collectively,
our findings have revealed GLP/G9a as a key regulator of cogni-
tion, motivation, and adaptive behavior in adult mice.
RESULTS
Conditional Ablation of GLP and G9a in Postnatal
Neurons Erases Euchromatic H3K9 Dimethylation
To address the role of GLP and G9a in adult brain function, we
employed conditional GLP and G9a gene inactivation in post-natal mouse neurons. Gene exons encoding the SET-domain
of GLP (Figure 1A) or G9a (Sampath et al., 2007) were flanked
with loxP sites in vivo. The SET-domain is essential for the
histone lysine methyltransferase activity of GLP and G9a (Tachi-
bana et al., 2002, 2005). The functional inactivation of GLP and
G9a genes in postnatal neurons was accomplished by using
Cre recombinase driven by the Ca2+/Calmodulin-dependent
protein kinase II alpha gene promoter (Camk2a-Cre). This
promoter is specifically active in postnatal forebrain neurons
and Camk2a-Cre mice have been successfully employed for
conditional modification of numerous genes in the forebrain
(Casanova et al., 2001; Zhang et al., 2004). In addition toNeuron 64, 678–691, December 10, 2009 ª2009 Elsevier Inc. 679
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enable conditional ablation of GLP or G9a specifically in dopa-
mine 2 receptor (Drd2) or dopamine 1 receptor (Drd1) expressing
medium spiny neurons (MSNs) in the striatum (Gong et al., 2007).
The immunohistochemical analysis of brain tissues from
Camk2a-Cre; GLPfl/fl mice showed GLP deficiency in neurons
of the cortex, hippocampus, striatum, and hypothalamus (Fig-
ure 1B). Postnatal, forebrain-specific deficiency of GLP led to
drastic reduction in neuronal euchromatic H3K9me2 levels
(Figures 1C and S1). Similar changes in euchromatic H3K9me2
levels occurred in neurons of Camk2a-Cre mice homozygous
for the mutant G9a allele (Camk2a-Cre; G9afl/fl) (Figure 1C), con-
firming the previously reported essential role of the GLP/G9a
complex in euchromatic H3K9me2 (Peters et al., 2003; Rice
et al., 2003; Sampath et al., 2007; Tachibana et al., 2002,
2005). Similarly, the Cre-mediated alteration of G9a specifically
in Drd1- or Drd2-expressing neurons in the striatum resulted in
loss of euchromatic H3K9me2 (Figure S1). As previously shown
for G9a-deficient ES cells and fibroblasts (Peters et al., 2003;
Sampath et al., 2007), the GLP/G9a-deficient neurons still
show heterochromatic H3K9me2 (Figures 1C, S1, and S2), which
may derive from enzymatic demethylation of heterochromatic
H3K9me3. In agreement with the previously reported selective
role of GLP/G9a in formation of euchromatic H3K9me2 in cells
of various types (Peters et al., 2003; Rice et al., 2003; Sampath
et al., 2007; Tachibana et al., 2002, 2005), the postnatal,
neuron-specific deficiency of GLP and G9a had no impact on
neuronal heterochromatic H3K9me3 (Figure S2).
GLP/G9a Control Expression of Lineage-Specific Genes
in Adult Neurons
Conditional inactivation of GLP or G9a in striatum, hippo-
campus, hypothalamus, or cortex led to upregulation of a large
number of genes (Figure 2A, Tables S1–S9). Comparison of
gene expression within the functionally distinct, GLP- or G9a-
deficient brain regions, as well as the cross-area comparison,
revealed about 60 genes that collectively comprise a genetic
‘‘signature’’ of GLP or G9a deficiency in the adult forebrain
(Figures 2B–2D). In addition to the commonly expressed genes,
each of the individual G9a- or GLP-deficient brain areas shows
upregulation of additional neuronal genes depending on the
specific brain region (Tables S2–S9). Combined GLP and G9a
deficiencies (Camk2a-Cre; GLPfl/fl; G9afl/fl) had no additional
impact on gene expression changes as compared to mice with
a single methyltransferase deficiency (data not shown). The
vast majority of the ‘‘signature’’ genes encode for proteins that
are normally not expressed in adult neurons (Figures 2C and
2D). A significant fraction of these genes is involved in develop-
ment and function of the skeletal, muscular, cardiovascular,
hematological, and immune systems (Figures 2C and 2D). The
degree of GLP and G9a impact on repression of nonneuronal
genes is highlighted by neuronal expression of Afamin (Afm)
or a-fetoprotein (Afp) in the striatum and cortex of GPL- or
G9a-deficient mice (Tables S1, S4, S5, S8, and S9). Afamin
and a-fetoprotein belong to the family of serum albumins and
are highly expressed in the embryonic liver but are transcription-
ally silenced in mature neurons (Lichenstein et al., 1994; Nguyen
et al., 2005). In addition to suppression of genes of nonneuronal680 Neuron 64, 678–691, December 10, 2009 ª2009 Elsevier Inc.lineage, GLP and G9a appear to control development-stage-
dependent neuronal gene expression. In particular, deficiency
in GLP or G9a in adult neurons reactivates expression of
the transcriptional regulator Dach2 (Tables S1–S11), which is
expressed during embryonic brain, eye, and limb development
(Davis et al., 2001). Upregulation of Dach2 is particularly inter-
esting in view of the human DACH2 gene localization on the
X chromosome in a region that is affected in a number of human
mental retardation syndromes (Davis et al., 2001).
The neuron-specificity of the observed gene expression
changes was validated by using the bacTRAP approach (Doyle
et al., 2008; Heiman et al., 2008) that enables analysis of cell-
type-specific mRNA expression in tissues, which are composed
of multiple different cell types. Expression of an eGFP-tagged
ribosomal protein selectively in Drd1 or Drd2 MSNs (Drd1-Cre;
Drd1-bacTRAP; G9afl/fl or Drd2-Cre; Drd2-bacTRAP; G9afl/fl)
allows Drd1 or Drd2 cell-type-specific polyribosome associated
mRNA purification. Comparative analysis of polyribosome asso-
ciatedmRNA of G9a-deficient and wild-type Drd1 or Drd2MSNs
showed that G9a deficiency in Drd1 or Drd2 MSNs leads to
neuron-intrinsic expression of most of the previously identified
nonneuronal/neuron-progenitor genes, including Afm, Afp,
Anxa10, Bank1, Ces7, Corin, Dach2, Defb1, Expi, Gbe1, Gkn1,
Lama2, Lamb3,Musk,Myh1, Nxf3, Olfm4, Serpinb1b, Serpinb5,
Ttn, and Tnnt2 (Tables S1, S10, and S11). This result indicates
that the derepression of nonneuronal genes in GLP- or G9a-defi-
cient postnatal neurons is likely to be neuron intrinsic.
Unaltered Neuronal Architecture in the Absence of GLP
or G9a
Deficiency in GLP or G9a and ensuing changes in gene expres-
sion had no apparent impact on the structural organization of the
affected brain areas (Figure 3A). Moreover, the specific neuronal
cell architecture in the striatum and the hippocampus was not
altered by forebrain-specific postnatal GLP or G9a deficiency
(Figures 3B–3E). Similarly, the lack of GLP/G9a had no major
impact on regulation of neuronal morphology and basal electro-
physiological features of Drd2-expressing MSNs in the striatum
of Drd2-Cre;G9afl/flmice (Figure 4). Preservation of neuronal cell
survival, morphology, and cell-type-specific electrophysiolog-
ical features in GLP- or G9a-deficient neurons rules out an
essential role of GLP/G9a and H3K9me2 in regulation of vital
cellular processes. Similar conclusions have been achieved by
studies that evaluated the impact of G9a deficiency on fibro-
blasts, peripheral lymphocytes, and cardiomyocytes (Sampath
et al., 2007; Shirato et al., 2009; Thomas et al., 2008).
Deficiency in GLP/G9a Leads to Complex Behavioral
Abnormalities and Cognitive Impairment in Adult Mice
In humans, genetic alterations of the GLP gene are associated
with a severemental retardation syndrome that is further charac-
terized by craniofacial abnormalities, hypotonia, obesity, and
a gradual decline in goal-directed cognition and behavior,
including a loss of interest in the environment, reduced motor
activity, and emotional responsiveness (Cormier-Daire et al.,
2003; Kleefstra et al., 2006, 2009; Kramer and van Bokhoven,
2009; Verhoeven et al., 2009). Mental retardation in humans is
defined by impaired cognitive function and deficits in adaptive
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Figure 2. Deficiency in GLP or G9a Alters Gene Expression in Adult Neurons
(A) Alteration of gene expression in GLP/G9a-deficient adult forebrain. Gene expression analysis was performed using normalized expression values from Affy-
metrix Mouse Genome 430 2.0 arrays. The gene expression levels in the striatum, hippocampus, and hypothalamus of Camk2a-Cre;GLPfl/fl (n = 4) and Camk2a-
Cre;G9afl/fl (n = 4) were compared to the respective gene expression values in control mice. The number of significantly >1.5-fold up- and downregulated genes
was determined using Welch t test and Benjamin Hochberg procedure (p < 0.05).
(B–D) Deficiency in GLP or G9a establishes a common pattern of altered gene expression.
(B) The first three Venn diagrams show the number of genes with the significantly changed expression levels in GLP-deficient (red) versus G9a-deficient (blue)
hippocampus, hypothalamus, and striatum. Overlapping genes for each specific brain region are shown in yellow and are compared in the fourth Venn diagram.
(C and D) Each Venn diagram shows the number of genes with the significantly changed expression levels in GLP (C) or G9a (D) deficient hippocampus (red),
hypothalamus (green), and striatum (blue). Expression levels of genes that are commonly affected by GLP (56 genes) or G9a (62 genes) deficiencies in all three
brain regions (white) are shown as a heat map after hierarchical clustering was performed. Scale of gene expression goes from no detectable expression (blue) to
the highest expression (red). Ingenuity pathway analysis has been used to assign these genes to a physiological process, and the significantly enriched functions
(p < 0.05) with their corresponding genes are listed by significance.Neuron 64, 678–691, December 10, 2009 ª2009 Elsevier Inc. 681
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Figure 3. Postnatal Forebrain-Specific GLP or G9a Deficiency Does Not Affect Brain Morphology or Neuronal Architecture
(A) The region-specific brain structures of 12-week-old Camk2a-Cre; GLPfl/fl (left panel), Camk2a-Cre; G9afl/fl (right panel), and control mice were analyzed using
standard Nissl staining. Representative images from sagittal brain sections of the hippocampus, cortex, and striatum are shown.
(B–E) Individual GLP-deficient and control Golgi-Cox-stained granule cells in the dental gyrus of the hippocampus (B), medium spiny neurons in the striatum (C),
and hippocampal pyramidal cells and their dendrites (D and E) were analyzed and representative images are shown.behaviors in response to the environment (APA, 2000). Similarly,
postnatal forebrain-specific ablation of GLP or G9a (Camk2a-
Cre; GLPfl/fl or Camk2a-Cre; G9afl/fl) in the mouse brain leads
to complex behavioral abnormalities. Starting around 6–8 weeks
of age, Camk2a-Cre; GLPfl/fl and Camk2a-Cre; G9afl/fl mice
show a diminished exploratory behavior in response to a new682 Neuron 64, 678–691, December 10, 2009 ª2009 Elsevier Inc.environment. When challenged to explore a novel space in the
open field, the GLP and G9a mutant mice traveled significantly
less than control mice (Figures 5A and 5B) and failed to explore
the space as judged by the significantly reduced vertical
episodes and lower center/total distance ratio (Figures 5C and
5D). Notably, a similar level of reduced locomotor activity and
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Figure 4. G9a-Deficient Drd2-Expressing Medium Spiny Neurons Maintain Wild-Type Electrophysiological and Morphological Properties
(A) Drd2 MSNs (n = 15 cells) in the striatum of Drd2-Cre; Drd2-eGFP; G9afl/fl mice responded to hyperpolarizing and depolarizing intrasomatic current steps in
a prototypical fashion, displaying inward rectification and nonadapting trains of action potentials.
(B) Drd2 MSNs lacking G9a retain Drd2 MSN-typical action potential waveforms, following 500 ms, suprathreshold current injection. Inset: the rate of change of
the membrane voltage/time plotted against voltage displays a normal action potential threshold.
(C) Frequency-current plot demonstrating a Drd2 MSN-typical pattern with a small but significant negative gain in excitability of Drd2 MSNs lacking G9a. Note:
Markedly different frequency-current plot for closely related dopamine 1 receptor (Drd1) MSN. Significance was determined using rank-sum test (p<0.05), data
are shown as means, error bars represent ± SEM.
(D) Reconstruction of biocytin-filled Drd2 MSNs revealed normal Drd2 MSN morphology in the absence of G9a. Wild-type Drd2 MSNs are shown in black;
G9a-deficient Drd2 MSNs are shown in red.exploration can be observed in mice with a haploinsufficiency in
GLP (GLP+/) (Figures 5E–5F), a genetic condition similar to the
one in patients with altered function of a single GLP allele in all
cells. Combined postnatal forebrain-specific deficiency of GLP
and G9a (Camk2a-Cre; GLPfl/fl; G9afl/fl) does not potentiate the
abnormal behavioral symptoms observed in mice with single
enzyme deficiency (Figures 5C and 5D), confirming the essential
role of a functional GLP/G9a complex in regulation of motor
activity and explorative behavior. Importantly, none of the
observed behavioral aberrations is found inmice with aCamk2a-
Cre-mediated ablation of the histone lysine methyltransferase
Ezh2 (CamK2a-Cre; Ezh2fl/fl mice) (Figures 5C and 5D), which
is essential for H3K27 methylation (Cao et al., 2002; Su et al.,
2003) and has been shown to play an important role in lineage-
specific gene expression and differentiation of various types of
cells including neurons and astrocytes (Bracken et al., 2006;
Cao and Zhang, 2004; Hirabayashi et al., 2009).
Abnormal exploratory behavior in the absence of GLP/G9a
could conceivably reflect a defect in motor function or balance.
However, the Camk2a-Cre; GLPfl/fl mice did not display any
reduction in motor activity or balance during the standard
accelerated rotarod analysis. In fact, the mutant mice seemed
to perform even slightly better than their littermate controls
(Figure 6A). Likewise, the elevated plus maze analysis, a testused to diagnose anxiety-like behavior in rodents, did not reveal
any anxiety-like phenotype that could explain the observed
reduction in exploratory behavior (Figure 6B). On the contrary,
the Camk2a-Cre; GLPfl/fl and the Camk2a-Cre; G9afl/fl mice
showed no evidence that they were aware of the potential
danger of open, unprotected areas. While wild-type mice
avoided the bright and open arms of the elevated plus maze,
the mutant mice showed a significant increase in the percentage
of entries into the open arms and time spent in the open arms as
compared to their littermate controls (Figure 6B). GLP/G9a-defi-
cient mice also showed a significant decrease in total arm
entries (Figure 6B), which is consistent with the previously
described reduction in explorative behavior in the open field
(Figure 4).
The reduction in locomotion and exploration in postnatal,
neuron-specific GLP/G9a-deficient mice could as well represent
a general loss of curiosity and interest in the environment,
implying potential deficits in the motivation or reward mecha-
nism. To address the ability of these mice to seek/respond to
rewards independently from their impaired locomotor activity
and exploration, GLP/G9a-deficient mice were tested for their
preference for sucrose, a sweet-tasting natural reward. Wild-
type mice, when given a choice to drink regular water versus
1% sucrose, clearly prefer sucrose. Mice with a postnatal,Neuron 64, 678–691, December 10, 2009 ª2009 Elsevier Inc. 683
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Figure 5. Deficiency of GLP/G9a Results in Reduced Exploration and Locomotor Activity
(A–D) Reduced exploratory behavior in the absence of GLP/G9a in postnatal forebrain neurons. Open-field analysis was used to measure locomotor activity and
exploratory behavior. The distance traveled (cm) during 1 hr of open-field analysis was determined for Camk2a-Cre; GLPfl/fl (n = 21) (A) and Camk2a-Cre; G9afl/fl
(n = 12) (B) mice and is shown in 10 min bins. The total number of vertical episodes (C) and center/total distance ratio (D) during 1 hr in the open field are shown.
The analysis includedmice with combinedGLP/G9a brain-specific deficiencies (Camk2a-Cre;GLPfl/fl;G9afl/fl, n = 8) as well asmice with brain-specific ablation of
the histone methyltransferase Ezh2 (Camk2a-Cre; Ezh2fl/fl, n = 5).
(E and F) Haploinsufficiency in GLP impairs locomotor activity and exploration. (E) The total distance traveled (cm) and (F) the total number of vertical episodes
during 1 hr of open-field analysis are shown for GLPfl/fl (n = 22), Camk2a-Cre; GLP+/fl (n = 18), Camk2a-Cre; GLPfl/fl (n = 14), and GLP+/ (n = 8) mice. Data are
shown as means, error bars represent + SEM. *p% 0.05, **p < 0.01, ***p < 0.001.neuron-specific deficiency in GLP or G9a almost completely
lacked the preference for sucrose (Figure 6C). Decreased
sucrose preference may indicate an underlying dysfunction in
the motivation/reward mechanism in these mice.
Contextual and cued fear conditioning is a behavioral test that
evaluates the ability of mice to learn and remember associations
between environmental cues and an aversive experience. The
mice learn to associate a neutral context (test chamber) and
a neutral stimulus (audio cue) with an aversive stimulus (mild
foot shock). Learned association of the previous neutral cues
with the aversive stimulus leads to the exhibition of a freezing684 Neuron 64, 678–691, December 10, 2009 ª2009 Elsevier Inc.response, which is characterized by an immobile and tense
posture. Analysis of the Camk2a-Cre; GLPfl/fl mice using the
standard fear conditioning paradigm demonstrated that while
initial pain sensitivity and freezing in response to mild foot shock
were not affected by GLP deficiency, the mutant mice did not
remember their negative experience (Figure 6D). The freezing
response to the contextual conditioned fear, as well as to the
audio cued conditioned fear was significantly impaired in the
GLP mutant mice as compared to their littermate controls
(Figure 6D). Thus, the deficiency of GLP in postnatal neurons
causes severe defects in learning and memory.
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Figure 6. Deficiency of GLP/G9a in Postnatal Forebrain Neurons Results in Complex Behavioral Abnormalities
(A) Unaltered locomotor function and balance inCamk2a-Cre;GLPfl/flmice. Locomotor function and balance were studied using the accelerated rotarod analysis.
The latency of Camk2a-Cre;GLPfl/fl and control mice (n = 7 each) to fall off the rod (sec) during accelerated rotarod analysis for three consecutive days with three
trials/day is shown.
(B) Lack of awareness of potential danger in GLP- and G9a-deficient mice. The percentage of open arm entries, percentage of time spent in open arms, and total
arm entries during a 5 min period in an elevated plus maze are shown. The experimental groups included Camk2a-Cre; GLPfl/fl (n = 18), Camk2a-Cre; G9afl/fl
(n = 15), and respective control mice.
(C) Deficits in motivation and reward in the absence of GLP/G9a. Sucrose preference test on Camk2a-Cre; GLPfl/fl, Camk2a-Cre; G9afl/fl, and respective control
mice (n = 5 each) showed a decreased sucrose/water intake (ratio) in the absence of GLP/G9a.
(D) Impaired learning and memory in the absence of GLP. The percentage of freezing responses for Camk2a-Cre;GLPfl/fl and their controls (n = 13) during a stan-
dard contextual fear analysis are shown.
Data are shown as means, error bars represent ± SEM. *p% 0.05, **p < 0.01, ***p < 0.001.Many of the mental retardation syndromes in humans and
mice are frequently associated with the development of obesity
(Cormier-Daire et al., 2003; Fyffe et al., 2008; Goldstone and
Beales, 2008). The same is true for the Camk2a-Cre; GLPfl/fl
and the Camk2a-Cre; G9afl/fl mice, which became obese and
almost doubled their body weight as compared to their con-
trols by 5–6 months of age (Figure S3). Importantly, the
described increase in body weight appears several weeks after
the manifestation of reduced locomotion and exploration in
these mice and therefore could be a consequence of, but
not a reason for, the behavioral abnormalities described above
(Figure S3).
Deficiency of GLP/G9a in Drd1 or Drd2 Neurons
Alters Their Responsiveness to Cell-Type-Specific
Stimuli In Vivo
Mice lacking G9a specifically in Drd1- or Drd2-expressing MSNs
only (Drd1-Cre; G9afl/fl, Drd2-Cre; G9afl/fl) did not display the
spontaneous locomotor or exploratory abnormalities observed
in the Camk2a-Cre-expressing mice (Figures 7A–7F). However,challenge with a Drd1 or Drd2 cell-specific stimulus revealed
an important role of GLP/G9a in regulation of cell-type-specific
behavioral responses to environmental signals. Locomotor
activity is regulated by the Drd1 and Drd2 MSNs in opposite
directions; either increased Drd1 or decreased Drd2 neuronal
activity leads to an increase of locomotion in mice. Activation
of Drd1-expressing MSNs via the dopamine 1 receptor leads
to an increase of locomotor activity and exploration in wild-
type mice. Loss of G9a in Drd1 MSNs led to a reduction
of Drd1-agonist-induced locomotor activity and explorative
behavior (Figures 7A, 7C, and 7E). On the other hand, decreased
activity of Drd2 neurons is achieved either by inhibiting the aden-
osine-2-a (A2a) receptor or by activating the Drd2 receptor.
Injection of caffeine, an A2a-receptor antagonist, which specifi-
cally reduces the activity of Drd2 MSNs, induced an increase
in locomotor and exploratory activity in wild-type mice. Drd2
cell-specific deletion of G9a led to a hyper-responsiveness to
caffeine, which was marked by a significantly higher increase
in locomotor and exploratory response upon Drd2 MSN inhibi-
tion in vivo (Figures 7B, 7D, and 7F). In summary, deficiency ofNeuron 64, 678–691, December 10, 2009 ª2009 Elsevier Inc. 685
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Figure 7. Selective Deficiency of GLP/G9a in Drd1- or Drd2-Expressing Neurons Alters the Responsiveness to Cell-Type-Specific Stimuli
Open-field analysis was used to assess the locomotor activity and exploratory behavior ofDrd1-Cre;G9afl/fl (A, C, and E, left column) andDrd2-Cre;G9afl/fl (B, D,
and F, right column) mice. To trigger Drd1 or Drd2 neuron-specific behavior, Drd1-Cre; G9afl/fl (n = 10) (A, C, and E), Drd2-Cre; G9afl/fl (n = 9) (B, D, and F), and
littermate control mice were treated with the Drd1-agonist SKF 81297 or the A2a-antagonist caffeine, respectively.
(A and B) The distance traveled (cm) during open-field analysis is shown. Data are shown in 5 min bins; consecutive conditions from left to right are: 20 min expo-
sure to new environment, 20 min post saline injection, and 30 min post Drd1-agonist SKF 81297 (5 mg/kg ip) injection (A), or 45 min post A2a-antagonist caffeine
(10 mg/kg ip) injections (B).
(C and D) The total distance traveled (cm) for each of the three conditions is shown.
(E and F) The total number of vertical episodes during each of the three conditions is shown. G9a-deficient mice are shown in light gray, littermate controls in dark
gray; data are shown as means, error bars represent ± SEM. **p < 0.01, ***p < 0.001.GLP/G9a in either of the two distinct neuronal populations in the
striatum is associated with an alteration of the responsiveness
of these cells to specific stimuli/inhibitors in vivo and reveals
a significant reduction of cell-type-specific activity in both
neuronal populations. These data demonstrate neuron/brain-
region-specific functions of GLP/G9a in regulation of specific
behavioral responses.686 Neuron 64, 678–691, December 10, 2009 ª2009 Elsevier Inc.DISCUSSION
We have identified GLP/G9a as key regulators of cognition and
adaptive behavior in adult mice. The mechanism of GLP/G9a
involvement in brain function is likely to reflect the ability of these
enzymes to maintain neuron-specific transcriptional homeo-
stasis and to protect adult neurons from expression of numerous
Neuron
Epigenetic Control of Behavior and Cognitionnonneuronal and neuronal progenitor genes. It is conceivable
that ectopic expression of regulatory proteins that are involved
in calcium and cAMP signaling (Bank1, Annexin-10, ArhGAP15,
CaBP5, MuSK, Plce1) and cytoskeletal function (myosin-1,
myosin-7, myomesin-2, titin, Tnnt2) may interfere significantly
with the function of the tightly regulated intracellular sig-
naling networks. Additionally, proteins of the laminin family like
Lama2, Lama3, and Lamb3 that become upregulated in the
absence of GLP/G9a are known to control cell-to-cell communi-
cation (Sche´ele et al., 2007) and may, therefore, interfere with
neuronal connectivity in the brain. Finally, several of the upregu-
lated ‘‘signature’’ proteins including a-fetoprotein, afamin, car-
boxylesterase 7, b-defensin 1, gastrokine-1, olfactomedin-4,
serpin B1b, and serpin B5 have been described as potent
secreted regulators of various cell functions (Bailey et al.,
2006; Benarafa et al., 2002; Holmes et al., 2008; Jensen et al.,
2009; Niyonsaba et al., 2005; Oien et al., 2004). Production of
these proteins by neurons could induce secondary changes in
neighboring neurons or nonneuronal cells. Overall, it is likely
that multiple gene defects rather than a single gene alteration
are responsible for the complex behavioral changes in the
absence of GLP/G9a.
Our data show that deficiency in GLP/G9a and ensuing
changes in gene expression have a differential impact on spe-
cialized brain areas. Inactivation of GLP/G9a in large numbers
of functionally diverse neurons in the postnatal forebrain leads
to a mental-retardation-like phenotype in adult mice. Contrary
to forebrain-specific GLP/G9a deficiency in the Camk2a-Cre
mice, ablation of these enzymes in highly specialized Drd1 or
Drd2 neurons in the striatum causes behavioral changes only
after pharmacological perturbation of Drd1 or Drd2 cell function.
It is conceivable that the observed differences in the severity of
the basal behavioral phenotypes are simply proportional to the
size and functional diversity of the affected neuronal popula-
tions. Accordingly, the potential impact of GLP/G9a deficiency
in specialized brain areas or neuronal subpopulations, such as
Drd1- or Drd2-expressing MSNs, could be revealed only after
perturbation of these neurons.
Comparison of the complex behavioral abnormalities in mice
with conditional postnatal GLP/G9a deficiency revealed a strong
resemblance to the human mental retardation syndrome associ-
ated with the subtelomeric deletion of the human chromosome
9 (9q34), which includes the histone lysine methyltransferase
GLP/EHMT1 gene. In addition to major defects in cognition
and learning, the 9q34 syndrome is further characterized by
obesity, childhood hypotonia, and a gradual, age-dependent
development of severe apathetic behavior, reduced motor
activity, and loss of goal-directed activities (Cormier-Daire
et al., 2003; Kleefstra et al., 2006, 2009; Kramer and van Bok-
hoven, 2009; Verhoeven et al., 2009). The potential causal role
of theGLP/EHMT1 gene alterations (OMIM607001) in the human
9q34mental retardation syndrome has been underscored by the
identification of various intragenic GLP/EHMT1 mutations in
patients with a mental retardation syndrome clinically indistin-
guishable from 9q34 deletion syndrome (Kleefstra et al., 2009;
Kramer and van Bokhoven, 2009). Five of the identified muta-
tions in the GLP/EHMT1 gene predict a premature termination
codon resulting in nonsense-mediated mRNA decay, whereasone of the mutations leads to an amino acid substitution that is
predicted to affect the conformation and hence the activity of
the highly conserved, histone methyltransferase encoding
SET-domain of the GLP/EHMT1 protein (Kleefstra et al., 2009).
The presence of key symptoms of the human 9q34 mental
retardation syndrome in mice with a postnatal, neuron-specific
GLP/G9a deficiency supports a causal role of GLP/G9a in
impaired neuron-specific function in the human disease. In
humans, deficiency in GLP is likely to affect both the develop-
ment and the function of the adult neurons. Our findings suggest
that deficiency in GLP/G9a in the postnatal mouse brain is suffi-
cient to cause complex behavioral changes. The latter finding
indicates a possible role of GLP/G9a regulation of adult brain
function, including cognition, in normal individuals. It has been
demonstrated recently that the protein level and histone methyl-
transferase activity of G9a can be regulated by oxygen concen-
tration (Chen et al., 2006). Therefore, it is possible that changes
in local oxygen concentrations in the brain may affect changes
in brain function due to alteration of GLP/G9a-mediated gene
regulation. Thus, it seems plausible that genetically predeter-
mined or environmentally induced changes of enzymes control-
ling H3K9me2 methylation may determine individual differences
in cognition and environmental adaptation in mice and humans.
EXPERIMENTAL PROCEDURES
Cloning of Targeting Construct and Generation of GLPfl/fl Mice
To create theGLP targeting vector, a region of theGLP genomic locus contain-
ing the long and short arms of homology was recombinogenically subcloned
from a BAC clone (RPCI24-156K12; BL/6; CHORI, Oakland CA, USA) into
pBlueScriptIIKS+ essentially as described (Lee et al., 2001; Sampath et al.,
2007; Yu et al., 2000), using primers which inserted a 50 AscI site and a 30
FseI site. The properly recombined plasmid was digested with NheI, and an
annealed double-stranded oligonucleotide containing the upstream loxP site
and a BsrGI site was inserted. The vector was then digested with BamHI,
and a NsiI fragment from pZeroloxP-FRT-neoR-FRT(-) containing the down-
stream loxP site and FRT-flanked neo gene was inserted and screened for
proper orientation. The resulting plasmid was digested with AscI and FseI to
release the targeted locus, which was inserted into XhoI-digested pDTA-TK
to produce the final targeting construct. Induced deletion of exon 23 is pre-
dicted to lead to out-of-frame splicing and Nonsense-Mediated Decay of the
transcript.
E14.1 (129/Ola) embryonic stem cells were transfected, selected, and used
to produce chimeric mice as described (Torres and Kuhn, 1997). Chimeras
were crossed to C57/BL6 and germline transmission was assessed by coat
color, PCR and Southern blot analysis (GLP-probe-B: CCTGTTAAACAT
GGCTGCTTG). Deletion of the FRT-flanked neo gene was accomplished by
crossing of mice carrying theGLPTarg allele in the germline to FLPe-transgenic
mice (Rodrı´guez et al., 2000). Routine genotypingwas performed by tail biopsy
and PCR using following primers: GLP-type-1: GGGTTGTGCTCAGAGTTTC
TACCTC, GLP-type-2: TCCCTCATCGCCCACAT TTCTG, GLP-type-3: CCGG
AGATGAGGAAGAGGAGAACAG.
Generation of Neuron-Specific GLP, G9a, and Ezh2 Mutant Mice
GLPfl/fl,G9afl/fl (Sampath et al., 2007) and Ezh2fl/fl (Su et al., 2003) were bred to
Camk2a-Cre (Casanova et al., 2001) mice to generate Camk2a-Cre; GLPfl/fl
and Camk2a-Cre; G9afl/fl and Camk2a-Cre; GLPfl/fl; G9afl/fl and Camk2a-Cre;
Ezh2fl/fl mice, respectively. GLP+/ mice were generated by crossing GLPfl/fl
with mice that express Cre-recombinase under the control of the ubiquitously
expressed CMV promotor (CMV-Cre mice, Jackson Laboratory). Drd2-bac-
TRAP (Heiman et al., 2008) and Drd2-eGFP (Heintz, 2004) mice were bred to
Drd2-Cre (ER44 line from Gensat [Gong et al., 2007]) and G9afl/fl mice to
generate Drd2-Cre; Drd2-bacTRAP; G9afl/fl and Drd2-bacTRAP; G9afl/flNeuron 64, 678–691, December 10, 2009 ª2009 Elsevier Inc. 687
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control mice. Drd1-bacTRAP (Heiman et al., 2008) mice were bred to Drd1-
Cre (EY262 line from Gensat [Gong et al., 2007]) and G9afl/fl mice to generate
Drd1-Cre; Drd1-bacTRAP; G9afl/fl and Drd1-bacTRAP; G9afl/fl control mice
and genotyping was performed as previously described. All mice were back-
crossed to the C57Bl/6 background for R4 generations. Mice were housed
under standard laboratory conditions at the Rockefeller University Compara-
tive Bioscience Center (CBC). Protocols were approved by the Rockefeller
University Institutional Animal Care and Use Committee.
Immunohistochemistry and Indirect Immunofluorescense
Eight- to twelve-week-old sex- and age-matched Camk2a-Cre; GLPfl/fl,
Camk2a-Cre;G9afl/fl,Drd2-Cre;Drd2-eGFP;G9afl/fl, and their respective litter-
mate controls were anesthetized with pentobarbitol and transcardially
perfused with 10 ml of phosphate-buffered saline (PBS) followed by 40 ml of
4% paraformaldehyde (PFA) in PBS. Brains were processed as previously
described (Schaefer et al., 2007). For GLP immunohistochemistry, sections
underwent antigen retrieval by heating in citrate solution (pH = 6.0), were incu-
bated with anti-GLP antibody (1:1000, R&D Systems, Minneapolis, MN) and
visualized by the avidin-biotin-peroxidase complex method (Vector Laborato-
ries, Burlingame, CA) as recommended by the manufacturer. DAB enhanced
liquid substrate system (Sigma-Aldrich) was used to detect peroxidase
activity, and sections were mounted using Crystal Mount solution (Biomedia,
Foster City, CA).
GFP (1:5000, ab6556), H3K9me2 (1:500, ab1220), and H3K9me3 (1:1000,
ab8898, all Abcam, Cambridge, MA) were visualized using indirect immunoflu-
orescence analysis (Alexa Fluor 546/488 labeled goat anti-mouse/anti-rabbit
IgGs (H+L) dilution 1:500, Invitrogen Corporation, Carlsbad, CA). Draq5 (Bio-
status Limited, Leicestershire, UK) was used to counterstain the nucleus and
sections were mounted using Prolong Gold antifade (Invitrogen Corporation,
Carlsbad, CA).
Brain Morphology Analysis
Sagittal brain sections of 12-week-old Camk2a-Cre; GLPfl/fl, Camk2a-Cre;
G9afl/fl and their respective littermate controls were visualized using standard
Nissl-stain (FD NeuroTechnologies, Inc., Ellicott City, MD). Coronal sections of
12- to 16-week-old Camk2a-Cre; GLPfl/fl, Camk2a-Cre; G9afl/fl and their
respective littermate controls (n = 3/genotype) were stained using the FD
Rapid GolgiStain Kit (FD NeuroTechnologies, Inc., Ellicott City, MD) as recom-
mended. All sections were visualized on a Zeiss LSM510 confocal miroscope
(Carl Zeiss, Thornwood, NY).
Electrophysiological Analysis
Three Drd2-Cre; Drd2-eGFP; G9afl/fl and Drd2-eGFP; G9afl/fl control mice
between postnatal days 35–40 were anesthetized with ketamine/xylazine
and perfused transcardially with ice-cold artificial CSF (aCSF) containing
(in mM) 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 2.0 CaCl2, 1.0 MgCl2, 25 NaHCO3,
and 12.5 glucose, bubbled continuously with carbogen (95%O2 and 5%CO2).
The brains were rapidly removed, glued to the stage of a VT1000S slicer (Leica,
Nussloch, Germany), and immersed in ice-cold aCSF. Striatal slices were cut
at a thickness of 240 mm and transferred to a holding chamber, where they
were submerged in aCSF, incubated at 35C for 30 min, and returned to
room temperature before recording. Recordings were made at room temper-
ature (20C–22C) with patch electrodes fabricated from filamented, thick-wall
borosilicate-glass (Sutter Instruments, Novato, CA) pulled on a Flaming-Brown
puller (P-97; Sutter). Pipette resistance was typically3–5 MUwhen filled with
internal solution consisting of (in mM) 135 KMeSO4, 5 KCl, 10 Na-phosphocre-
atine, 5.0 EGTA, 0.5 CaCl2, 2.0 Mg-ATP, 0.5 Na3-GTP, 5 HEPES, 0.2% w/v
biocytin, pH 7.25–7.30, 300 mOsm. The liquid junction potential in recordings
was 7 mV and not corrected for. MSNs within the dorsal striatum were iden-
tified by their somatic morphological characteristics under IR-DIC optics.
Somatic eGFP expression was verified routinely in cell-attach mode using epi-
fluorescence microscopy to confirm cell identity before breaking into whole-
cell mode. Somatic whole-cell patch-clamp recordings were obtained with
a MultiClamp 700B amplifier (Molecular Devices, Union City, CA) interfaced
to a Pentium-based PC running pClamp9 (Molecular Devices). For current-
clamp recordings, the amplifier bridge circuit was adjusted to compensate688 Neuron 64, 678–691, December 10, 2009 ª2009 Elsevier Inc.for electrode resistance and subsequently monitored. For anatomical recon-
struction, slices in which eGFP positive Drd2 cells were recorded in whole-
cell mode for at least 30 min were flat-mounted on nitrocellulose filters
(Millipore; Billerica, MA), fixed in 4% paraformaldehye for 72 hr, and reacted
with 2 mg/ml streptavidin-Alexa Fluor 594 (Invitrogen; Carlsbad, CA) in 2%
Triton-X, 1% NGS prepared in PBS overnight. Sections were then washed,
coverslipped, and imaged as detailed previously (Gertler et al., 2008).
RNA Preparation
Total RNA from cortex, hippocampus, hypothalamus, and striatum of
12-week-old Camk2a-Cre; GLPfl/fl, Camk2a-Cre; G9afl/fl, and Camk2a-Cre;
GLPfl/fl; G9afl/flmice and age and sex matched littermate controls (n = 4/geno-
type) was extracted using the Trizol/chloroform technique as recommended
by the manufacturer (Invitrogen Corporation, Carlsbad, CA). After extraction,
RNA was precipitated overnight at 80C in isopropanol with sodium acetate
and Glycoblue (Ambion, Austin, TX), washed twice with 70% ethanol, resus-
pended in water, and further purified using an Rneasy Micro Kit (QIAGEN,
Valencia, CA) with in-columnDNase digestion. Purified sampleswere analyzed
using a Nanodrop 1000 spectrophotometer (Thermo Scientific, Wilmington,
DE) and a Bioanalyzer (Agilent Technologies, Santa Clara, CA) in order to
assess mRNA quantity and quality, as reflected by rRNA levels and integrity.
Purification of mRNA from bacTRAP Mice
Polyribosome associated mRNAs from age and sex matched Drd2-Cre; Drd2-
bacTRAP; G9afl/fl and Drd2-bacTRAP; G9afl/fl, or Drd1-Cre; Drd1-bacTRAP;
G9afl/fl and Drd1-bacTRAP; G9afl/fl mice (n = 3 3 5 mice/genotype) were
obtained as previously described using amix of twomonoclonal anti-GFP anti-
bodies (19C8, 19F7) for the immunoprecipitation reaction (Doyle et al., 2008;
Heiman et al., 2008).
Gene Expression Analysis
PurifiedmRNA or total RNAwas amplified and processed for using the Affyme-
trix two cycle cDNA Synthesis kit (Affymetrix, Santa Clara, CA) as previously
described (Doyle et al., 2008; Heiman et al., 2008). Affymetrix Mouse Genome
430 2.0 arrays were used in all experiments.
Information regarding the array design and features can be found at www.
affymetrix.com. Mouse Genome 430 2.0 arrays were scanned using the Gen-
eChip Scanner 3000 (Affymetrix, Santa Clara, CA) and globally scaled to 150
using the Affymetrix GeneChip Operating Software (GCOS v1.4). Three/four
biological replicates were performed for each experiment. GeneChip CEL files
were imported together into Genespring GX 7.3.1 (Agilent Technologies, Santa
Clara, CA), processed with the GC-RMA algorithm, and expression values on
each chip were normalized to that chip’s 50th percentile. Statistical analysis
was carried out to determine which genes are differentially expressed in the
GLP- and G9a-deficient cortex, striatum, hippocampus, and hypothalamus
as compared to their respective controls, and G9a-deficient Drd1 and Drd2
MSNs as compared to their respective controls. The minimum information
about a microarray experiment (MIAMI) compliant summary of the gene
expression analysis can be found in the Supplemental Experimental Proce-
dures section.
Behavioral Analysis
All behavioral tests have been performed on 6- to 16-week-old Camk2a-Cre;
GLPfl/fl, Camk2a-Cre; GLP+/fl, GLPfl/-, Camk2a-Cre; G9afl/fl, Camk2a-Cre;
GLPfl/fl; G9afl/fl, Camk2a-Cre; Ezh2fl/fl, Drd2-Cre; G9afl/fl, Drd1-Cre; G9afl/fl
mice and their respective age and sex matched littermate controls. Mice
were housed with a 12 hr light/dark cycle (lights on at 7 AM and off at 7 PM)
with access to food and water ad libitum. All behavioral tests were performed
between 9 AM and 5 PM. Experiments were conducted by an experimenter
blind to the genotypes of the mice. GraphPad Prism version 4.03 for Windows
(GraphPad Software, San Diego, CA) was used for statistical analysis of the
data. Statistical analysis was performed using Student’s t test, one-way,
two-way, or two-way repeated-measures ANOVA with Bonferoni posttest.
Open-Field Analysis
Locomotion and exploratory behavior wasmeasured using the open field anal-
ysis in a new environment (clear plexiglas 40 3 40 3 30 cm open-field arena).
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activity system (AccuScan Instruments, Columbus, OH). Mice were recorded
for the total distance moved (cm), number of vertical episodes (rearing), and
distance moved in the center of the arena (cm). The distance moved in the
center (cm) was divided by the total distance moved (cm) to obtain center/total
distance ratio values. Data were collected at 5–10min intervals over 20–60min
test sessions. Saline, Drd1-agonist SKF 81297 (5 mg/kg in saline, Tocris, Ellis-
ville, MO) and caffeine (10 mg/kg in saline, Sigma, St. Louis, MO) have been
used for intraperitoneal injections.
Rotarod Analysis
The motor function and balance of mice was analyzed using the standard
accelerated rotarod test (4–40 rpm/5 min, Med Associates, St. Albans, VT).
The time taken for the mice to fall from the rod was measured in seconds. If
a mouse, clinging on to the rod, completed two full passive rotations, the
mouse was removed from the trial and the time was recorded as fallen from
the rod. If a mouse stayed on the rod until the end of the 5 min trial, a time
of 300 s was recorded. After one training trial, mice were subjected to three
consecutive trials/day with 5 min intertrial intervals for three consecutive
days and measurements were taken from each trial.
Elevated Plus Maze Analysis
The elevated plus maze test was used to determine the unconditioned
response to a potentially dangerous environment. Anxiety-related behavior
was measured by the degree to which the rodent avoided the open arms of
the maze. The mice were placed at the junction of the elevated four-arm
maze in which two arms are open and two are enclosed. The number of times
the animal entered each of the arms and the time spent in each arm was
recorded for 5 min by the EthoVision video-tracking system (Noldus Informa-
tion Technology Inc., Leesburg, VA). Total arm entries, percentage of open arm
entries, and percentage of time spend in the open arms were calculated.
Sucrose Preference Test
Sucrose preference ofCamk2a-Cre;GLPfl/fl,Camk2a-Cre;G9afl/fl and their sex
and age matched littermate controls (n = 5/genotype) was measured as an
index for motivation and reward. All animals were single housed 3–4 days prior
to the beginning of the sucrose preference testing. Two 50ml bottles fittedwith
two-balled sipper tubes (Ancare, Bellmore, NY) were positioned on the food
rack. The experiment started with 2 days of water in both bottles, followed
by 2 days with 1% sucrose in both bottles, and 4 days of a water-sucrose
choice. The fluid levels in both bottles were measured every evening at
6 PM, and the bottle position was switched daily to avoid side biases. The total
amount of sucrose was divided by the total amount of water consumed during
the 4 days of water-sucrose choice to calculate the sucrose/water preference
ratio.
Fear Conditioning Analysis
Memory and learning abilities of Camk2a-Cre; GLPfl/fl and their sex and age
matched littermate controls (n = 13/genotype) have been analyzed using
a standard fear conditioning paradigm (Med Associates, St. Albans, VT). The
test chamber (neutral context) was made of clear Plexiglas. The bottom of
the test chamber was a grid floor used to deliver a mild electric foot shock.
The test chamber was placed inside a sound-attenuated chamber. Mice
were observed through a window in the front of the sound-attenuated
chamber. One mouse was placed in the test chamber (house lights on) and al-
lowed to explore freely for 2 min. A white noise (80 dB), which served as the
conditioned stimulus, was then presented for 30 s, followed by a mild (2 s,
0.5 mA) foot shock, which served as the unconditioned stimulus. Two minutes
later the same sequence of auditory cue-shock pairing was repeated. The
mouse was removed from the chamber 30 s later and returned to its home
cage. Freezing behavior was recorded every 10 s during the time spend in
the test chamber. Responses (run, jump, and vocalize) to the foot shock
were also recorded. Twenty-four hours later, the mouse was placed back
into the test chamber for 5 min, and the presence of freezing behavior was re-
corded (context test). Two hours later, the mouse was tested for its freezing
respond to the auditory cue. Environmental and contextual cues were
changed for the auditory cue test: a black Plexiglas triangular insert was
placed in the chamber to alter its shape, spatial cues, and lightening; the
wire grid floor was covered with white Plexiglas; and orange extract was
placed in the chamber to alter the smell. The auditory cue test was divided
into two phases. During the first phase, freezing behavior was recorded for3 min in the absence of the auditory cue. In the second phase, the auditory
cue was turned on, and freezing was recorded for another 3 min. The number
of freezing intervals for each test was converted to a percentage of freezing
value.
Body Weight
Body weight of Camk2a-Cre; GLPfl/fl and Camk2a-Cre; G9afl/fl mice and their
age and sex matched littermate controls was recorded monthly starting at
4 weeks of age (n = 10–15).
SUPPLEMENTAL DATA
Supplemental Data include three figures, eleven tables, and Supplemental
Experimental Procedures and can be found with this article online at http://
www.cell.com/neuron/supplemental/S0896-6273(09)00933-7.
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